Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Sugen continues to focus on TK inhibitors

Feb. 19, 1997

Bard presents new bladder cancer diagnostic test

Feb. 18, 1997

Immunomedics' LeukoScan approved for European market

Feb. 18, 1997

AD diagnostic reaches market

Feb. 18, 1997

X-ray contrast agents from Schering AG

Feb. 14, 1997

DiagnoCure prepares for clinical trials of bladder cancer diagnostic

Feb. 13, 1997

Patent coverage for lung cancer detection technology

Feb. 13, 1997

Meridian receives approval for ulcer test

Feb. 12, 1997

Study suggests benefit of EchoGen for prostate cancer diagnosis

Feb. 12, 1997

Use of Home Access HIV test system encouraged

Feb. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.